October 29, 2015 Off

FDA approved BMS’s Yervoy

By Dino Mustafić

U.S. Food and Drug Administration (FDA) has approved BMS’s Yervoy (ipilimumab) 10 mg/kg for the adjuvant treatment of patients with cutaneous melanoma with pathologic involvement of regional lymph nodes of more than 1 mm who have undergone complete resection including total lymphadenectomy.

October 28, 2015 Off

Plandai in agreement with Bal Pharma for Phytofare

By Dino Mustafić

Plandaí Biotechnology, Inc., has executed an Exclusive Distribution Agreement with Bal Pharma Ltd., an India-based manufacturer and exporter of pharmaceutical finished formulation/bulk drugs and distributor of nutraceuticals ingredients.